Amiodarone Induced Interstitial Lung Disease: An Enigma

Authors

  • Prakash Aryal Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Srijan Pantha Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Kum Bahadur Gurung Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Augraj Uprety Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Nensi Shah Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Anup Timsina Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Dipesh Mandal Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Krishna Chandra Yadav Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Aarati Adhikari Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Rejina Shahi Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Deebya Raj Mishra Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal
  • Narendra Bhatta Department of Pulmonary, Critical Care and Sleep Medicine, BPKIHS, Dharan, Nepal

DOI:

https://doi.org/10.3126/nrj.v3i1.69216

Keywords:

Amiodarone, Interistitial Lung Disease, Non-Specific Interistitial Pneumonia

Abstract

Amiodarone is an anti-arrhythmic drug that has potential to cause Interstitial Lung Disease (ILD) commonly non-specific Interistitial pneumonia. We present a 75-year male presenting with gradual onset progressive shortness of breath and dry cough after undergoing coronary artery bypass grafting (CABG) and was kept on amiodarone therapy post-surgery to control arrhythmias. The patient was diagnosed as amiodarone induced Non-Specific Interstitial Pneumonia (NSIP) after excluding alternative diagnosis. Early recognition and stoppage of amiodarone, prompt treatment with corticosteroid and respiratory support had favorable clinical outcome in this case.

Downloads

Download data is not yet available.

Downloads

Published

2024-08-26

How to Cite

Aryal, P., Pantha, S., Gurung, K. B., Uprety, A., Shah, N., Timsina, A., Mandal, D., Yadav, K. C., Adhikari, A., Shahi, R., Mishra, D. R., & Bhatta, N. (2024). Amiodarone Induced Interstitial Lung Disease: An Enigma. Nepalese Respiratory Journal, 3(1), 24–26. https://doi.org/10.3126/nrj.v3i1.69216

Issue

Vol. 3 No. 1 (2024): Nepalese Respiratory Journal

Section

Case Reports

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.